Qilian International Holding Group Limited Cash Flow Conversion Efficiency
Qilian International Holding Group Limited cash flow conversion efficiency. Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has a cash flow conversion efficiency ratio of 0.006x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.49 Million) by net assets ($399.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Qilian International Holding Group Limited (2017–2025)
Cash flow conversion efficiency of Qilian International Holding Group Limited from 2017 to 2025. This chart illustrates how Qilian International Holding Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Qilian International Holding Group Limit for real-time trading data and today's change.
Qilian International Holding Group Limited Cash Flow Conversion Ratio Explained
Qilian International Holding Group Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Qilian International Holding Group Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qilian International Holding Group Limited ranked by their cash flow conversion efficiency. Also see market value of Qilian International Holding Group Limit for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ryvu Therapeutics SA
WAR:RVU
|
-0.553x |
|
Stel Holdings Limited
NSE:STEL
|
0.005x |
|
GBM Resources Ltd
AU:GBZ
|
-0.012x |
|
Payton -L
TA:PAYT
|
0.009x |
|
Talisker Resources Ltd
TO:TSK
|
-0.381x |
|
Ulusoy Un Sanayi ve Ticaret AS
IS:ULUUN
|
-0.156x |
|
The Century Co., Ltd.
KO:002420
|
0.009x |
|
Icon Group
TA:ICON
|
-0.040x |
Annual Cash Flow Conversion Efficiency for Qilian International Holding Group Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Qilian International Holding Group Limited from 2017 to 2025. Review Qilian International Holding Group Limit free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $392.14 Million | $-2.37 Million | -0.006x | -149.02% |
| 2024-09-30 | $44.09 Million | $544.24K | 0.012x | +75.34% |
| 2023-09-30 | $44.35 Million | $312.21K | 0.007x | -96.94% |
| 2022-09-30 | $54.96 Million | $12.65 Million | 0.230x | +3681.28% |
| 2021-09-30 | $56.67 Million | $345.03K | 0.006x | -96.54% |
| 2020-09-30 | $28.84 Million | $5.08 Million | 0.176x | +786.70% |
| 2019-09-30 | $22.64 Million | $-580.20K | -0.026x | -110.23% |
| 2018-09-30 | $17.72 Million | $4.44 Million | 0.250x | +27.54% |
| 2017-09-30 | $13.66 Million | $2.68 Million | 0.196x | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and… Read more